Stay updated on Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Record History page shows an updated revision label, changing from Revision: v3.5.2 to Revision: v3.5.3, indicating a new build of the history interface.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedIPDSharing and Study Status entries were added in the latest version (61, Revision: v3.5.2). This is a metadata/UI update and does not change the core study information or results.SummaryDifference0.3%

- Check55 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded revision v3.4.2 to the history; removed the funding-lapse notice and revision v3.4.1.SummaryDifference0.4%

- Check97 days agoChange DetectedA site-wide funding notice was added and the page revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Preventing Melanoma Recurrence Clinical Trial page.